期刊文献+

人参皂苷Rg_l及其代谢产物的药代动力学研究 被引量:25

Pharmacokinetics of ginsenosides Rg_1 and its metabolites in rats
原文传递
导出
摘要 研究静注和灌胃给予一定量人参皂苷Rg1后,其原形和3种代谢产物的药代动力学。以Wistar大鼠为模型动物,以LC-MS/MS法测定血浆中人参皂苷Rg1及其代谢产物的浓度,并计算药代动力学参数。灌胃给药后,在血浆中检测到人参皂苷Rg1、Rh1、F1和原人参三醇4种物质。其Tmax分别为0.92、3.64、5.17和7.30h,MRT分别为2.68、5.06、6.65和5.33h,AUC0-t为2363.5、4185.5、3774.3和396.2ng·mL-1·h。静注给药后,在血浆中检测到人参皂苷Rg1、Rh1和F13种物质。其T1/2β分别为3.12、5.87和6.87h,MRT分别为1.92、5.99和7.13h,AUC0-t分别为1454.7、597.5和805.6ng·mL-1·h。结果表明灌胃给药后,大鼠体内的人参皂苷Rg1代谢产物的量超过原形药,且代谢产物的吸收和消除速率相对缓慢。静注给药后,大鼠体内的人参皂苷Rg1以原形为主,但仍有少量代谢产物存在,且代谢产物的吸收和消除速率相对缓慢。 To study the pharmacokinetics of ginsenosides Rg1 and its metabolites after iv and oral admini-stration in Wistar rats,the LC-MS/MS method was selected to determine ginsenosides Rg1 and its metabolites in plasma and their pharmacokinetic parameters were calculated.After oral administration of ginsenosides Rg1 to rats,ginsenosides Rg1,Rh1,F1 and protopanaxatriol (Ppt) could be detected in plasma.Their Tmax were 0.92,3.64,5.17,and 7.30 h,respectively;MRT were 2.68,5.06,6.65,and 5.33 h,respectively;AUC0-t were 2 363.5,4 185.5,3 774.3,and 396.2 ng·mL',余凌英-1·h,respectively.After iv administration of ginsenosides Rg1 to rats,ginsenosides Rg1,Rh1 and F1 could be detected in plasma.Their T1/2βs were 3.12,5.87,and 6.87 h,respectively;MRTs were 1.92,5.99,and 7.13 h,respectively;AUC0-ts were 1 454.7,597.5,and 805.6 ng·mL-1·h,respectively.So,it can be concluded that after oral administration,the amounts of metabolites were higher than the prototype in vivo,and the distribution and elimination of the metabolites were relatively slow.After iv administration,the amount of prototype were higher than that of the metabolites in vivo,and the distribution and elimination of the metabolites were relatively slow.
出处 《药学学报》 CAS CSCD 北大核心 2010年第5期636-640,共5页 Acta Pharmaceutica Sinica
基金 四川省教育厅基金课题(07ZB019)
关键词 人参皂苷RG1 代谢产物 LC-MS/MS 药代动力学 ginsenoside Rg1 metabolite LC-MS/MS pharmacokinetics
  • 相关文献

参考文献4

二级参考文献39

  • 1赵朝晖,陈晓春,金建生,朱元贵,师广斌,曾育琦,李永坤,彭旭.人参皂苷Rg1对细胞衰老过程中p21,cyclin E和CDK2表达的影响[J].药学学报,2004,39(9):673-676. 被引量:24
  • 2张均田.人参皂苷Rg1的促智作用机制——对神经可塑性和神经发生的影响[J].药学学报,2005,40(5):385-388. 被引量:64
  • 3李章万,徐秀荣.色谱分析中生物样品的前处理方法[J].药物分析杂志,1996,16(1):55-59. 被引量:23
  • 4韩旻,韩丽妹,王青松,白志华,方晓玲.三七皂苷的口服吸收机制[J].药学学报,2006,41(6):498-505. 被引量:45
  • 5Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitrite oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
  • 6Lin KT, Xue JY, Nomen M, Spur B, Wong PY. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995; 270: 16487-90.
  • 7Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo.J Neurochem 2000; 74: 2213-6.
  • 8Hunot S, Boissiere E Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, et al. Nitrite oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996; 72: 355-63.
  • 9Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994; 63: 793-806.
  • 10Jenner P, Olanow CW. Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders. In: Olanow CW, Jenner P, Youdim MBH, editors. Neurodegeneration and neuroprotection in Parkinson's disease. London: Academic Press;1996. p 24-45.

共引文献138

同被引文献362

引证文献25

二级引证文献162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部